Company Statement: PharMerica and Omnicare to exchange info to facilitate assessment of antitrust risk
MLex Summary: Pharmerica has agreed with Omnicare to exchange market information to facilitate their assessment of the antitrust risk in connection with the potential combination of the companies. Nevertheless, PharMerica's Board...To view the full article, register now.
Already a subscriber? Click here to view full article